Carroll Patrick Harrison sold $830K of HIMS
Carroll Patrick Harrison (Chief Medical Officer) sold 23,726 shares of Hims & Hers Health, Inc. (HIMS) at $35.00 ($0.83M total) on 2026-06-18 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is a scheduled open-market transaction under a 10b5-1 plan, typically lowering interpretive weight versus discretionary selling.
Market read
Traders may briefly reassess near-term sentiment around insider activity, but there is no new fundamental information.
What to watch
The filing does not disclose any change in business outlook, guidance, or risk factors; the only actionable element is monitoring for future non-10b5-1 transactions or follow-on disclosures.
Background
The article is an SEC Form 4 insider transaction disclosure for Hims & Hers Health, Inc.
Ticker impact
SEC Form 4 shows CMO Carroll Patrick Harrison sold 23,726 shares of HIMS at $35 on 2026-06-18 under a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a disclosed open-market sale by an officer under a pre-arranged 10b5-1 plan, with no accompanying new company-specific operational or financial information.
Market effects
Minimal; insider-sale filings rarely reset sector expectations without additional company news.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish conviction, so traders may ignore it.
Key entities
- issuerHims & Hers Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderCarroll Patrick Harrison
Chief Medical Officer who sold shares under a 10b5-1 plan.
